These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Imaging of gastrointestinal stromal tumors before and after imatinib mesylate therapy.
    Author: Shankar S, Dundamadappa SK, Karam AR, Stay RM, van Sonnenberg E.
    Journal: Acta Radiol; 2009 Oct; 50(8):837-44. PubMed ID: 19735005.
    Abstract:
    Gastrointestinal stromal tumors (GISTs) account for the majority of gastrointestinal mesenchymal tumors. Recent advances in treatment using the molecular targeting agent imatinib mesylate have shown startling response rates and variegated imaging findings. We present the various imaging appearances of GIST on computed tomography (CT) and magnetic resonance imaging (MRI), both before and after treatment.
    [Abstract] [Full Text] [Related] [New Search]